Juergen Fleck

Juergen Fleck is an accomplished professional in clinical operations and development, currently serving as the Head of Development Operations at Ariceum Therapeutics since June 2023. With extensive experience in leading clinical operations, Fleck previously held the position of Head Of Clinical Operations at Recordati Rare Diseases, focusing on global endocrinology projects from April 2020 to May 2023. Prior to that, Fleck was at Advanced Accelerator Applications as Director of Development Operations, overseeing global clinical trials in radioligand therapies for oncology. A substantial tenure at Novartis included roles such as Franchise Clinical Operations Head in Global Medical Affairs for oncology, demonstrating expertise in managing clinical trials. Earlier career milestones involved significant positions at Actelion Pharmaceuticals, Pfizer, and Ardeypharm, covering roles from Senior Clinical Scientist to Clinical Study Manager. Fleck’s academic credentials include a PhD in Biochemistry and Development Biology from Ruhr University Bochum and a Postdoctoral degree in Biochemistry and Ecology from The University of Georgia.